Methylation

SAMe

S-Adenosylmethionine - universal methyl donor essential for 200+ methylation reactions including neurotransmitter synthesis and DNA methylation.

MethylationBrowse methylation|Related:MTHFR
SAMe pathway diagram

S-Adenosylmethionine (SAMe, also SAM or AdoMet) is the universal methyl donor in the body, participating in over 200 methylation reactions. It is synthesized from methionine and ATP by methionine adenosyltransferase (MAT), primarily in the liver. Methylation reactions using SAMe: DNA methylation (gene expression regulation), Histone methylation (epigenetics), Phospholipid synthesis (phosphatidylcholine from phosphatidylethanolamine), Neurotransmitter metabolism (catecholamine and serotonin degradation via COMT), Creatine synthesis (largest consumer of methyl groups), Protein methylation (signal transduction), and Detoxification (arsenic methylation, etc.).

After donating its methyl group, SAMe becomes S-adenosylhomocysteine (SAH), which is then converted to homocysteine. High SAH inhibits methylation reactions - the SAMe:SAH ratio determines methylation capacity.

SAMe synthesis

1

Methionine (dietary or from homocysteine remethylation)

2

ATP

3

Adequate B12 and folate (for homocysteine remethylation to methionine).

SAMe supplementation: Used therapeutically for depression (comparable to antidepressants in studies), osteoarthritis (supports cartilage), liver disease (the liver normally makes most SAMe; supplementation bypasses impaired synthesis), and fibromyalgia. Considerations: SAMe is unstable and requires enteric coating.

It can worsen bipolar disorder (may trigger mania). High doses may cause anxiety or insomnia. It provides methyl groups, so those who are already overmethylated may not tolerate it well. Typical therapeutic dose is 400-1600mg/day.

Metabolic Connections

SAMe connects to 20 other pathways.

SAMe Discussion